Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-12-08

Clinical Trial Update: Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating clarithromycin or sulfamethoxazole/trimethoprim versus observation in newly diagnosed multiple myeloma to address infection-related iss…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfamethoxazole-trimethoprim (sulfamethoxazole-trimethoprim)
  • clarithromycin (clarithromycin)

Snippet

Sponsor: Henrik Gregersen | Conditions: Multiple Myeloma, Infection | Phase 2 | Status: UNKNOWN